Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

• Michelle Mendenhall,

  Affiliation Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America

  ⨯
• Andrew Russell,

  Affiliation Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America

  ⨯
• Donald F. Smee,

  Affiliation Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America

  ⨯
• Jeffery O. Hall,

  Affiliation Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America

  ⨯
• Ramona Skirpstunas,

  Affiliations Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America, Department of Agriculture and Food, State of Utah, Logan, Utah, United States of America

  ⨯
• Yousuke Furuta,

  Affiliation Research Laboratories, Toyama Chemical Company, Ltd., Toyama, Japan

  ⨯
• Brian B. Gowen

  * E-mail: brian.gowen@usu.edu

  Affiliation Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America

  ⨯